摘要:
2025年5月19日, 北京大学药学院药事管理与临床药学系崔一民教授团队在Nature Communications杂志发表了题为“Intestinal permeability of N-acetylcysteine is driven by gut microbiota-dependent cysteine palmitoylation”的研究论文, 该研究首次揭示了肠道菌源性鞘脂代谢在调节N-乙酰半胱氨酸(N-Acetylcysteine, NAC)肠道渗透性评价中的关键作用。
Supporting:
北京大学药学院药事管理与临床药学系. 崔一民团队探索肠道菌群调控BCS药物渗透性评价的新方法[J]. 中国药学(英文版), 2025, 34(6): 602-604.
Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University Health Science Center. The research team of Prof. Yimin Cui explored a new method for evaluating the intestinal permeability of BCS drug regulated by gut microbiota[J]. Journal of Chinese Pharmaceutical Sciences, 2025, 34(6): 602-604.